Yubo International Biotech Limited (YBGJ)
USD 0.05
(0.0%)
USD 0.05
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 104.28 Thousand | 1.24 Million | 1.35 Million | - | - | - |
| Cost of Revenue | 51.63 Thousand | 423.72 Thousand | 114.27 Thousand | - | - | - |
| Gross Profit | 52.65 Thousand | 820.64 Thousand | 1.23 Million | - | - | - |
| Operating Expenses | 1.25 Million | 2.36 Million | 1.95 Million | -48 Thousand | -58 Thousand | 149 Thousand |
| Selling, General and Administrative Expenses | 1.04 Million | 1.49 Million | 1.2 Million | 48 Thousand | 58 Thousand | 149 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 211.22 Thousand | 870.56 Thousand | 750.55 Thousand | -96 Thousand | -116 Thousand | - |
| Cost and Expenses | 1.3 Million | 2.78 Million | 2.06 Million | 48 Thousand | 58 Thousand | 149 Thousand |
| Operating Income | -1.2 Million | -1.54 Million | -711.79 Thousand | -48 Thousand | -58 Thousand | -149 Thousand |
| Interest Expense | 229.00 | 427 Million | - | 100 Thousand | 86 Thousand | 75 Thousand |
| Income Tax Expense | -229.00 | -426.00 | 3.00 | - | - | - |
| Earnings before Tax | -1.2 Million | -1.54 Million | -711.8 Thousand | -148 Thousand | -144 Thousand | -224 Thousand |
| Net Income | -1.2 Million | -1.54 Million | -711.8 Thousand | -148 Thousand | -144 Thousand | -224 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.13 | -0.12 | -0.19 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.13 | -0.12 | -0.19 |
| Weighted Average Shares Outstanding | 118.72 Million | 118.13 Million | 118.17 Million | 1.17 Million | 1.17 Million | 1.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 118.72 Million | 118.13 Million | 118.17 Million | 1.17 Million | 1.17 Million | 1.17 Million |
| Gross Margin | 0.50 | 0.66 | 0.92 | - | - | - |
| EBIT Margin | -11.29 | -1.22 | -0.52 | - | - | - |
| Profit Margin | -11.55 | -1.24 | -0.53 | - | - | - |
| EBITDA | -1.17 Million | -1.52 Million | -698.73 Thousand | -48 Thousand | -58 Thousand | -149 Thousand |
| Earnings Before Tax Margin | -11.56 | -1.24 | -0.53 | - | - | - |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1430.00 | 156.61 Thousand | 104.28 Thousand | 66.52 Thousand | 14.58 Thousand | 7970.00 |
| Cost of Revenue | 545.00 | 98.92 Thousand | 51.63 Thousand | 37.58 Thousand | 4980.00 | 2119.00 |
| Gross Profit | 885.00 | 57.69 Thousand | 52.65 Thousand | 28.93 Thousand | 9600.00 | 5851.00 |
| Operating Expenses | 368.16 Thousand | 382.22 Thousand | 1.25 Million | -74.54 Thousand | 247.87 Thousand | 497.35 Thousand |
| Selling, General and Administrative Expenses | 201.38 Thousand | 275.62 Thousand | - | -204.48 Thousand | 321.02 Thousand | 448.78 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 368.16 Thousand | 106.59 Thousand | 211.22 Thousand | 129.93 Thousand | -73.15 Thousand | 48.57 Thousand |
| Cost and Expenses | 368.7 Thousand | 481.14 Thousand | 1.3 Million | -36.96 Thousand | 252.85 Thousand | 499.47 Thousand |
| Operating Income | -367.27 Thousand | -324.53 Thousand | -1.2 Million | 103.48 Thousand | -238.27 Thousand | -491.5 Thousand |
| Interest Expense | 51.00 | -135.00 | 229.00 | -17.00 | 174.00 | 59.00 |
| Income Tax Expense | - | 270.00 | -229.00 | -126.00 | -174.00 | 59.00 |
| Earnings before Tax | -367.32 Thousand | -316.66 Thousand | -1.2 Million | 103.6 Thousand | -238.09 Thousand | -491.55 Thousand |
| Net Income | -367.32 Thousand | -316.93 Thousand | -1.2 Million | 103.6 Thousand | -237.92 Thousand | -491.61 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | - | 0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | 0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 119.82 Million | 119.82 Million | 118.72 Million | 118.72 Million | 118.69 Million | 118.18 Million |
| Weighted Average Shares Outstanding (Diluted) | 119.82 Million | 119.82 Million | 118.72 Million | 118.72 Million | 118.69 Million | 118.18 Million |
| Gross Margin | 0.62 | 0.37 | 0.50 | 0.43 | 0.66 | 0.73 |
| EBIT Margin | -244.02 | -2.01 | - | 1.73 | -15.98 | -61.01 |
| Profit Margin | -256.87 | -2.02 | -11.55 | 1.56 | -16.32 | -61.68 |
| EBITDA | -348.95 Thousand | -314.97 Thousand | - | 114.88 Thousand | -232.99 Thousand | -486.21 Thousand |
| Earnings Before Tax Margin | -256.84 | -2.07 | -11.56 | 1.56 | -16.34 | -61.67 |
PRRSF
DCBO
TCLCONS
FMX
BEI-UN
MSON-B